BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21118378)

  • 1. New potent bisubstrate inhibitors of histone acetyltransferase p300: design, synthesis and biological evaluation.
    Kwie FH; Briet M; Soupaya D; Hoffmann P; Maturano M; Rodriguez F; Blonski C; Lherbet C; Baudoin-Dehoux C
    Chem Biol Drug Des; 2011 Jan; 77(1):86-92. PubMed ID: 21118378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisubstrate analogue structure-activity relationships for p300 histone acetyltransferase inhibitors.
    Sagar V; Zheng W; Thompson PR; Cole PA
    Bioorg Med Chem; 2004 Jun; 12(12):3383-90. PubMed ID: 15158807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azide-alkyne cycloaddition affording enzymatically tunable bisubstrate based inhibitors of histone acetyltransferase PCAF.
    van Ameijde J; Zwiebel AP; Ruijtenbeek R; Liskamp RM
    Bioorg Med Chem Lett; 2014 Jan; 24(1):113-6. PubMed ID: 24345448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological testing of novel pyridoisothiazolones as histone acetyltransferase inhibitors.
    Furdas SD; Shekfeh S; Bissinger EM; Wagner JM; Schlimme S; Valkov V; Hendzel M; Jung M; Sippl W
    Bioorg Med Chem; 2011 Jun; 19(12):3678-89. PubMed ID: 21353783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative.
    Ghizzoni M; Boltjes A; Graaf Cd; Haisma HJ; Dekker FJ
    Bioorg Med Chem; 2010 Aug; 18(16):5826-34. PubMed ID: 20655754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and analysis of potential prodrugs of coenzyme A analogues for the inhibition of the histone acetyltransferase p300.
    Cebrat M; Kim CM; Thompson PR; Daugherty M; Cole PA
    Bioorg Med Chem; 2003 Jul; 11(15):3307-13. PubMed ID: 12837541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-alkylamides as a new class of synthetic histone deacetylase inhibitors. 1. Design, synthesis, biological evaluation, and binding mode studies performed through three different docking procedures.
    Mai A; Massa S; Ragno R; Cerbara I; Jesacher F; Loidl P; Brosch G
    J Med Chem; 2003 Feb; 46(4):512-24. PubMed ID: 12570373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of p300 specific histone acetyltransferase inhibition by small molecules.
    Arif M; Pradhan SK; Thanuja GR; Vedamurthy BM; Agrawal S; Dasgupta D; Kundu TK
    J Med Chem; 2009 Jan; 52(2):267-77. PubMed ID: 19086895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and evaluation of cyclic amide/imide-bearing hydroxamic acid derivatives as class-selective histone deacetylase (HDAC) inhibitors.
    Shinji C; Maeda S; Imai K; Yoshida M; Hashimoto Y; Miyachi H
    Bioorg Med Chem; 2006 Nov; 14(22):7625-51. PubMed ID: 16877001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity relationships of truncated bisubstrate inhibitors of aminoglycoside 6'-N-acetyltransferases.
    Gao F; Yan X; Shakya T; Baettig OM; Ait-Mohand-Brunet S; Berghuis AM; Wright GD; Auclair K
    J Med Chem; 2006 Aug; 49(17):5273-81. PubMed ID: 16913716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Bisubstrate Inhibitors for Protein N-Terminal Acetyltransferase D.
    Deng Y; Deng S; Ho YH; Gardner SM; Huang Z; Marmorstein R; Huang R
    J Med Chem; 2021 Jun; 64(12):8263-8271. PubMed ID: 34110812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent inhibitors of acyl-CoA:cholesterol acyltransferase. 2. Structure-activity relationships of novel N-(2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)amides.
    Kataoka K; Shiota T; Takeyasu T; Minoshima T; Watanabe K; Tanaka H; Mochizuki T; Taneda K; Ota M; Tanabe H; Yamaguchi H
    J Med Chem; 1996 Mar; 39(6):1262-70. PubMed ID: 8632433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of isothiazol-3-one derivatives as inhibitors of histone acetyltransferases (HATs).
    Gorsuch S; Bavetsias V; Rowlands MG; Aherne GW; Workman P; Jarman M; McDonald E
    Bioorg Med Chem; 2009 Jan; 17(2):467-74. PubMed ID: 19101154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray crystallographic studies of serotonin N-acetyltransferase catalysis and inhibition.
    Wolf E; De Angelis J; Khalil EM; Cole PA; Burley SK
    J Mol Biol; 2002 Mar; 317(2):215-24. PubMed ID: 11902838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 3. Discovery of novel lead compounds through structure-based drug design and docking studies.
    Ragno R; Mai A; Massa S; Cerbara I; Valente S; Bottoni P; Scatena R; Jesacher F; Loidl P; Brosch G
    J Med Chem; 2004 Mar; 47(6):1351-9. PubMed ID: 14998325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-(1,3-Diaryl-3-oxopropyl)amides as a new template for xanthine oxidase inhibitors.
    Nepali K; Agarwal A; Sapra S; Mittal V; Kumar R; Banerjee UC; Gupta MK; Satti NK; Suri OP; Dhar KL
    Bioorg Med Chem; 2011 Sep; 19(18):5569-76. PubMed ID: 21862335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the reaction coordinate of the p300/CBP histone acetyltransferase with bisubstrate analogs.
    Karukurichi KR; Cole PA
    Bioorg Chem; 2011 Feb; 39(1):42-7. PubMed ID: 21111442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxime amides as a novel zinc binding group in histone deacetylase inhibitors: synthesis, biological activity, and computational evaluation.
    Botta CB; Cabri W; Cini E; De Cesare L; Fattorusso C; Giannini G; Persico M; Petrella A; Rondinelli F; Rodriquez M; Russo A; Taddei M
    J Med Chem; 2011 Apr; 54(7):2165-82. PubMed ID: 21417297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modeling studies toward the structural optimization of new cyclopeptide-based HDAC inhibitors modeled on the natural product FR235222.
    Di Micco S; Terracciano S; Bruno I; Rodriquez M; Riccio R; Taddei M; Bifulco G
    Bioorg Med Chem; 2008 Sep; 16(18):8635-42. PubMed ID: 18715788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.